MedMira (TSXV: MIR) has announced the launch of a clinical trial to evaluate its Multiplo TP/HIV rapid test for use as a self-test in Canada.
Multiplo is a dual HIV and syphilis rapid self-test that delivers immediate results from a simple finger-prick blood sample. The first participants have now been enrolled at the Cool Aid Community Health Centre in Victoria, British Columbia and at Women’s Health In Women’s Hands Community Health Clinic in Toronto.
Hermes Chan, CEO of MedMira remarked, “This is a critical next step in making our Multiplo TP/HIV test available for self-testing in Canada. We’re committed to providing a fast, accurate, and easy-to-use self-test that can deliver immediate results, helping people to know their status in the privacy of their homes and get connected to care. We believe this is the most direct and effective path to having an immediate impact on the HIV and Syphilis epidemics.”
